Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers

NCT01453907 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Anthrax

Interventions

DRUG: ETI-204, "Anthim"
DRUG: placebo

Sponsor

Elusys Therapeutics